Symbols / GMED Stock $80.00 +0.00% Globus Medical, Inc.

Healthcare • Medical Devices • United States • NYQ
GMED (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Keith W. Pfeil
Exch · Country NYQ · United States
Market Cap 10.86B
Enterprise Value 10.35B
Income 586.71M
Sales 3.10B
FCF (ttm) 341.06M
Book/sh 34.88
Cash/sh 4.64
Employees 6,000
Insider 10d —
IPO Aug 03, 2012
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 18.69
Forward P/E 15.53
PEG 1.49
P/S 3.50
P/B 2.29
P/C —
EV/EBITDA 10.95
EV/Sales 3.34
Quick Ratio 2.83
Current Ratio 4.56
Debt/Eq 2.45
LT Debt/Eq —
EPS (ttm) 4.28
EPS next Y 5.15
EPS Growth 66.70%
Revenue Growth 27.00%
EPS Gr Q/Q 64.70%
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA 8.18%
ROE 13.30%
ROIC —
Gross Margin 68.49%
Oper. Margin 21.32%
Profit Margin 18.92%
Shs Outstand 113.31M
Shs Float 111.72M
Insider Own 0.71%
Instit Own 101.57%
Short Float 3.03%
Short Ratio 2.31
Short Interest 3.41M
52W High 101.40
vs 52W High -21.10%
52W Low 51.79
vs 52W Low 54.47%
Beta 0.95
Impl. Vol. 45.25%
Rel Volume 0.74
Avg Volume 1.38M
Volume 1.03M
Target (mean) $110.00
Tgt Median $115.00
Tgt Low $87.00
Tgt High $122.00
# Analysts 11
Recom Buy
Prev Close $80.00
Price $80.00
Change 0.00%
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$110.00
Mean price target
2. Current target
$80.00
Latest analyst target
3. DCF / Fair value
$54.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$80.00
Low
$87.00
High
$122.00
Mean
$110.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-08 main RBC Capital Outperform → Outperform $120
2026-05-08 main Wells Fargo Overweight → Overweight $103
2026-05-08 main Needham Buy → Buy $117
2026-02-26 main Wells Fargo Overweight → Overweight $104
2026-02-25 main Barclays Overweight → Overweight $123
2026-02-25 main Needham Buy → Buy $114
2026-01-30 up Needham Hold → Buy $112
2026-01-09 main Canaccord Genuity Buy → Buy $112
2026-01-08 reit Piper Sandler Overweight → Overweight $115
2025-12-17 main Canaccord Genuity Buy → Buy $105
2025-12-17 main RBC Capital Outperform → Outperform $100
2025-12-17 init Freedom Capital Markets — → Hold $87
2025-12-02 main Morgan Stanley Overweight → Overweight $100
2025-11-18 reit Truist Securities Buy → Buy $105
2025-11-10 main Barclays Overweight → Overweight $114
2025-11-07 main RBC Capital Outperform → Outperform $92
2025-11-07 main Wells Fargo Overweight → Overweight $79
2025-11-07 up B of A Securities Neutral → Buy $91
2025-11-07 up Truist Securities Hold → Buy $93
2025-10-10 main RBC Capital Outperform → Outperform $88
News
RSS: Latest GMED news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-25 HULLER KELLY GRACE General Counsel — 20,000 $94.50 $1,890,000
2026-02-25 HULLER KELLY GRACE General Counsel — 20,000 $43.58 $871,600
2026-02-12 HULLER KELLY GRACE General Counsel — 10,000 $87.67 $876,700
2026-02-12 HULLER KELLY GRACE General Counsel — 10,000 $45.64 $456,400
2026-01-08 NORWALK LESLIE V Director — 2,000 $101.10 $202,200
2026-01-08 KLINE KYLE Chief Financial Officer — 3,594 $101.10 $363,353
2026-01-08 KLINE KYLE Chief Financial Officer — 3,594 $51.87 $186,421
2025-12-12 NORWALK LESLIE V Director — 4,000 $88.85 $355,400
2025-12-08 PAUL DAVID C Officer, Director and Beneficial Owner — 34,375 $25.52 $877,250
2025-12-01 KLINE KYLE Chief Financial Officer — 18,542 $90.00 $1,668,780
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,938.93
+16.65%
2,519.36
+60.62%
1,568.48
+53.34%
1,022.84
Operating Revenue
2,938.93
+16.65%
2,519.36
+60.62%
1,568.48
+53.34%
1,022.84
Cost Of Revenue
957.80
-7.50%
1,035.48
+88.90%
548.17
+107.86%
263.73
Reconciled Cost Of Revenue
799.15
-11.35%
901.46
+98.70%
453.68
+112.79%
213.21
Gross Profit
1,981.13
+33.51%
1,483.88
+45.43%
1,020.30
+34.41%
759.12
Operating Expense
1,443.94
+14.19%
1,264.49
+54.42%
818.89
+56.61%
522.87
Research And Development
147.25
-10.08%
163.75
+32.05%
124.01
+69.84%
73.02
Selling General And Administration
1,178.50
+20.09%
981.36
+52.42%
643.84
+49.00%
432.12
Total Expenses
2,401.74
+4.42%
2,299.97
+68.24%
1,367.06
+73.80%
786.59
Operating Income
537.19
+144.86%
219.39
+8.92%
201.42
-14.74%
236.25
Total Operating Income As Reported
479.82
+189.06%
165.99
+24.67%
133.14
-41.59%
227.95
EBITDA
814.03
+72.18%
472.78
+36.27%
346.94
+13.94%
304.50
Normalized EBITDA
756.71
+32.88%
569.46
+42.02%
400.96
+27.77%
313.82
Reconciled Depreciation
276.84
+9.26%
253.39
+74.12%
145.53
+113.22%
68.25
EBIT
537.19
+144.86%
219.39
+8.92%
201.42
-14.74%
236.25
Total Unusual Items
57.32
+159.29%
-96.68
-78.99%
-54.02
-479.56%
-9.32
Total Unusual Items Excluding Goodwill
57.32
+159.29%
-96.68
-78.99%
-54.02
-479.56%
-9.32
Special Income Charges
60.33
+212.98%
-53.40
+21.79%
-68.27
-722.58%
-8.30
Other Special Charges
—
0.31
-27.65%
0.43
-81.46%
2.34
Restructuring And Mergern Acquisition
-60.33
-212.98%
53.40
-21.79%
68.27
+1045.73%
5.96
Net Income
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Pretax Income
605.07
+401.21%
120.72
-27.01%
165.39
-31.94%
243.02
Net Non Operating Interest Income Expense
7.14
+270.47%
-4.19
-120.81%
20.13
+41.43%
14.23
Net Interest Income
7.14
+270.47%
-4.19
-120.81%
20.13
+41.43%
14.23
Other Income Expense
60.74
+164.29%
-94.48
-68.25%
-56.15
-652.22%
-7.46
Other Non Operating Income Expenses
3.41
+54.78%
2.21
+203.13%
-2.14
-215.26%
1.85
Gain On Sale Of Security
-3.01
+93.06%
-43.28
-403.56%
14.26
+1497.94%
-1.02
Tax Provision
67.20
+278.85%
17.74
-58.28%
42.52
-19.55%
52.85
Tax Rate For Calcs
0.00
-24.49%
0.00
-42.82%
0.00
+18.47%
0.00
Tax Effect Of Unusual Items
6.36
+144.77%
-14.21
-2.35%
-13.89
-586.62%
-2.02
Net Income Including Noncontrolling Interests
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Net Income From Continuing Operation Net Minority Interest
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Net Income From Continuing And Discontinued Operation
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Net Income Continuous Operations
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Normalized Income
486.91
+162.55%
185.45
+13.77%
163.00
-17.45%
197.47
Net Income Common Stockholders
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Diluted EPS
3.92
+422.67%
0.75
-29.91%
1.07
-42.16%
1.85
Basic EPS
3.98
+423.68%
0.76
-30.28%
1.09
-42.33%
1.89
Basic Average Shares
135.22
-0.38%
135.73
+20.02%
113.09
+12.56%
100.47
Diluted Average Shares
137.06
-0.59%
137.86
+20.27%
114.63
+11.68%
102.64
Diluted NI Availto Com Stockholders
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Amortization
118.19
-0.99%
119.37
+133.92%
51.03
+187.75%
17.73
Amortization Of Intangibles Income Statement
118.19
-0.99%
119.37
+133.92%
51.03
+187.75%
17.73
Depreciation Amortization Depletion Income Statement
118.19
-0.99%
119.37
+133.92%
51.03
+187.75%
17.73
Depreciation And Amortization In Income Statement
118.19
-0.99%
119.37
+133.92%
51.03
+187.75%
17.73
Total Other Finance Cost
-7.14
-270.47%
4.19
+120.81%
-20.13
-41.43%
-14.23
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5,302.76
+0.97%
5,251.75
+3.26%
5,086.08
+144.98%
2,076.13
Current Assets
2,125.61
-2.37%
2,177.26
+13.67%
1,915.37
+94.78%
983.34
Cash Cash Equivalents And Short Term Investments
557.24
-37.39%
890.06
+71.90%
517.79
+16.08%
446.06
Cash And Cash Equivalents
526.16
-32.93%
784.44
+67.87%
467.29
+210.56%
150.47
Other Short Term Investments
31.09
-70.57%
105.62
+109.16%
50.50
-82.92%
295.59
Receivables
743.66
+28.59%
578.33
+14.55%
504.87
+132.33%
217.31
Accounts Receivable
678.94
+21.74%
557.70
+10.82%
503.24
+135.99%
213.25
Gross Accounts Receivable
712.37
+24.28%
573.20
+11.92%
512.17
+134.97%
217.97
Allowance For Doubtful Accounts Receivable
-33.43
-115.63%
-15.51
-73.55%
-8.93
-89.12%
-4.72
Taxes Receivable
64.73
+213.71%
20.63
+1161.96%
1.64
-59.74%
4.06
Inventory
759.28
+15.18%
659.23
-22.27%
848.13
+183.68%
298.98
Raw Materials
162.25
+33.01%
121.98
+18.03%
103.35
+71.32%
60.32
Work In Process
64.46
+40.82%
45.77
+22.65%
37.32
+99.59%
18.70
Finished Goods
532.57
+8.36%
491.47
-30.53%
707.47
+221.64%
219.96
Prepaid Assets
—
—
—
—
Other Current Assets
65.43
+31.80%
49.64
+11.35%
44.58
+112.32%
21.00
Total Non Current Assets
3,177.15
+3.34%
3,074.49
-3.03%
3,170.71
+190.15%
1,092.78
Net PPE
628.24
+2.73%
611.56
-5.46%
646.86
+159.04%
249.72
Gross PPE
1,333.24
+15.20%
1,157.34
+7.90%
1,072.56
+80.95%
592.75
Accumulated Depreciation
-705.00
-29.17%
-545.79
-28.21%
-425.69
-24.10%
-343.04
Properties
0.00
0.00
0.00
0.00
Land And Improvements
10.85
+11.49%
9.73
-0.17%
9.75
+17.77%
8.28
Buildings And Improvements
127.57
+27.41%
100.13
-2.27%
102.45
+98.89%
51.51
Other Properties
1,194.82
+14.07%
1,047.48
+9.07%
960.36
+80.19%
532.97
Goodwill And Other Intangible Assets
2,180.10
-2.13%
2,227.50
-5.58%
2,359.14
+803.73%
261.05
Goodwill
1,435.03
+0.18%
1,432.39
-0.15%
1,434.54
+626.46%
197.47
Other Intangible Assets
745.06
-6.30%
795.12
-14.00%
924.60
+1354.37%
63.57
Investments And Advances
71.82
+8.60%
66.13
-12.32%
75.43
-84.79%
495.85
Non Current Deferred Assets
218.22
+131.65%
94.20
+781.61%
10.69
-78.12%
48.84
Non Current Deferred Taxes Assets
218.22
+131.65%
94.20
+781.61%
10.69
-78.12%
48.84
Other Non Current Assets
78.78
+4.91%
75.10
-4.45%
78.59
+110.57%
37.32
Total Liabilities Net Minority Interest
729.51
-32.10%
1,074.42
-1.26%
1,088.12
+373.61%
229.75
Current Liabilities
498.50
-41.76%
855.91
+118.15%
392.35
+146.44%
159.20
Payables And Accrued Expenses
269.49
+38.47%
194.62
+21.51%
160.16
+110.99%
75.91
Payables
132.25
+10.27%
119.93
+42.36%
84.24
+78.78%
47.12
Accounts Payable
98.85
+31.60%
75.12
+32.55%
56.67
+56.98%
36.10
Other Payable
—
—
—
—
Current Accrued Expenses
137.24
+83.76%
74.68
-1.62%
75.92
+163.71%
28.79
Pensionand Other Post Retirement Benefit Plans Current
167.10
+10.07%
151.82
+7.81%
140.82
+163.94%
53.35
Total Tax Payable
33.40
-25.48%
44.81
+62.54%
27.57
+150.21%
11.02
Income Tax Payable
4.16
-61.26%
10.72
+178.93%
3.85
+288.38%
0.99
Current Debt And Capital Lease Obligation
14.74
-96.75%
453.60
+3690.42%
11.97
+371.88%
2.54
Current Debt
—
443.35
—
—
Other Current Borrowings
—
443.35
—
—
Current Capital Lease Obligation
14.74
+43.80%
10.25
-14.36%
11.97
+371.88%
2.54
Current Deferred Liabilities
27.66
+24.91%
22.14
+20.53%
18.37
+30.28%
14.10
Current Deferred Revenue
27.66
+24.91%
22.14
+20.53%
18.37
+30.28%
14.10
Other Current Liabilities
19.51
-42.16%
33.74
-44.72%
61.03
+358.63%
13.31
Total Non Current Liabilities Net Minority Interest
231.01
+5.72%
218.50
-68.60%
695.78
+886.23%
70.55
Long Term Debt And Capital Lease Obligation
103.92
+24.32%
83.59
-83.56%
508.44
+14531.28%
3.48
Long Term Debt
—
—
417.40
—
Long Term Capital Lease Obligation
103.92
+24.32%
83.59
-8.18%
91.04
+2519.77%
3.48
Non Current Deferred Liabilities
23.76
-0.56%
23.89
-71.70%
84.42
+4645.42%
1.78
Non Current Deferred Taxes Liabilities
23.76
-0.56%
23.89
-71.70%
84.42
+4645.42%
1.78
Other Non Current Liabilities
103.34
-6.93%
111.03
+7.88%
102.92
+57.62%
65.30
Stockholders Equity
4,573.25
+9.48%
4,177.33
+4.49%
3,997.96
+116.53%
1,846.37
Common Stock Equity
4,573.25
+9.48%
4,177.33
+4.49%
3,997.96
+116.53%
1,846.37
Capital Stock
0.14
-1.46%
0.14
+0.74%
0.14
+36.00%
0.10
Common Stock
0.14
-1.46%
0.14
+0.74%
0.14
+36.00%
0.10
Share Issued
112.63
-18.04%
137.42
+0.80%
136.34
+36.07%
100.19
Ordinary Shares Number
112.63
-18.04%
137.42
+0.80%
136.34
+36.07%
100.19
Additional Paid In Capital
3,169.81
+4.57%
3,031.24
+5.59%
2,870.75
+354.99%
630.95
Retained Earnings
1,387.96
+20.40%
1,152.81
+1.37%
1,137.27
-8.28%
1,239.95
Gains Losses Not Affecting Retained Earnings
15.35
+323.67%
-6.86
+32.68%
-10.19
+58.62%
-24.63
Other Equity Adjustments
15.35
+323.67%
-6.86
+32.68%
-10.19
+58.62%
-24.63
Total Equity Gross Minority Interest
4,573.25
+9.48%
4,177.33
+4.49%
3,997.96
+116.53%
1,846.37
Total Capitalization
4,573.25
+9.48%
4,177.33
-5.39%
4,415.36
+139.14%
1,846.37
Working Capital
1,627.11
+23.14%
1,321.35
-13.24%
1,523.03
+84.80%
824.14
Invested Capital
4,573.25
-1.03%
4,620.68
+4.65%
4,415.36
+139.14%
1,846.37
Total Debt
118.66
-77.91%
537.19
+3.23%
520.40
+8557.53%
6.01
Capital Lease Obligations
118.66
+26.45%
93.84
-8.90%
103.00
+1613.59%
6.01
Net Tangible Assets
2,393.15
+22.74%
1,949.83
+18.98%
1,638.82
+3.37%
1,585.33
Tangible Book Value
2,393.15
+22.74%
1,949.83
+18.98%
1,638.82
+3.37%
1,585.33
Available For Sale Securities
34.96
—
—
—
Held To Maturity Securities
36.85
—
—
—
Investmentin Financial Assets
71.82
+8.60%
66.13
-12.32%
75.43
-84.79%
495.85
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
753.45
+44.72%
520.64
+113.82%
243.50
+36.44%
178.47
Cash Flow From Continuing Operating Activities
753.45
+44.72%
520.64
+113.82%
243.50
+36.44%
178.47
Net Income From Continuing Operations
537.87
+422.28%
102.98
-16.19%
122.87
-35.39%
190.17
Depreciation Amortization Depletion
276.84
+9.26%
253.39
+74.12%
145.53
+113.22%
68.25
Depreciation And Amortization
276.84
+9.26%
253.39
+74.12%
145.53
+113.22%
68.25
Other Non Cash Items
-95.15
-136.26%
262.42
+178.40%
94.26
+3477.27%
2.63
Stock Based Compensation
49.78
-8.14%
54.19
+2.75%
52.74
+60.75%
32.81
Provisionand Write Offof Assets
32.34
-19.84%
40.34
+176.01%
14.62
+128.43%
6.40
Asset Impairment Charge
—
—
—
6.40
Deferred Tax
18.62
+114.79%
-125.90
-117.86%
-57.79
-160.04%
-22.22
Deferred Income Tax
18.62
+114.79%
-125.90
-117.86%
-57.79
-160.04%
-22.22
Operating Gains Losses
-0.07
-100.21%
30.76
+353.56%
-12.13
-4157.86%
0.30
Net Foreign Currency Exchange Gain Loss
-12.59
-149.94%
25.21
+284.38%
-13.67
0.00
Change In Working Capital
-66.80
+31.53%
-97.55
+16.33%
-116.60
-10.77%
-105.26
Change In Receivables
-52.18
+33.15%
-78.06
-56.39%
-49.91
+1.83%
-50.84
Changes In Account Receivables
-52.18
+33.15%
-78.06
-56.39%
-49.91
+1.83%
-50.84
Change In Inventory
-17.60
+41.06%
-29.86
+57.54%
-70.33
-13.90%
-61.74
Change In Prepaid Assets
11.13
+951.18%
1.06
-7.75%
1.15
+111.15%
-10.29
Change In Payables And Accrued Expense
42.70
+88.24%
22.69
+681.20%
2.90
-85.84%
20.50
Change In Accrued Expense
34.22
+581.21%
5.02
-70.67%
17.13
+181.37%
6.09
Change In Payable
8.49
-51.95%
17.66
+224.19%
-14.22
-198.65%
14.42
Change In Account Payable
8.49
-51.95%
17.66
+224.19%
-14.22
-198.65%
14.42
Change In Other Working Capital
-50.85
-280.14%
-13.38
-3178.68%
-0.41
+85.87%
-2.89
Investing Cash Flow
-355.01
-101.65%
-176.05
-158.11%
302.97
+374.52%
-110.36
Cash Flow From Continuing Investing Activities
-355.01
-101.65%
-176.05
-158.11%
302.97
+374.52%
-110.36
Net PPE Purchase And Sale
-164.68
-42.67%
-115.43
-47.47%
-78.27
-5.71%
-74.05
Purchase Of PPE
-164.68
-42.67%
-115.43
-47.47%
-78.27
-5.71%
-74.05
Capital Expenditure
-174.43
-51.11%
-115.43
-47.47%
-78.27
-5.71%
-74.05
Net Investment Purchase And Sale
71.96
+267.39%
-42.99
-106.35%
677.27
+13978.48%
-4.88
Purchase Of Investment
-107.53
+5.26%
-113.50
-12.78%
-100.64
+76.01%
-419.53
Sale Of Investment
179.49
+154.53%
70.52
-90.94%
777.91
+87.61%
414.65
Net Business Purchase And Sale
-252.55
-1332.07%
-17.64
+94.04%
-296.03
-841.71%
-31.43
Purchase Of Business
-252.55
-1332.07%
-17.64
+94.04%
-296.03
-841.71%
-31.43
Net Intangibles Purchase And Sale
-9.75
0.00
0.00
—
Purchase Of Intangibles
-9.75
0.00
0.00
—
Financing Cash Flow
-679.16
-2352.20%
-27.70
+88.05%
-231.82
-110.82%
-109.96
Cash Flow From Continuing Financing Activities
-679.16
-2352.20%
-27.70
+88.05%
-231.82
-110.82%
-109.96
Net Issuance Payments Of Debt
-449.99
0.00
0.00
—
Repayment Of Debt
-449.99
0.00
0.00
—
Short Term Debt Payments
-449.99
0.00
0.00
—
Net Short Term Debt Issuance
-449.99
0.00
0.00
—
Net Common Stock Issuance
-300.45
-250.23%
-85.79
+61.97%
-225.56
-56.11%
-144.49
Common Stock Payments
-300.45
-250.23%
-85.79
+61.97%
-225.56
-56.11%
-144.49
Repurchase Of Capital Stock
-300.45
-250.23%
-85.79
+61.97%
-225.56
-56.11%
-144.49
Proceeds From Stock Option Exercised
89.76
-18.73%
110.44
+790.85%
12.40
-70.28%
41.72
Net Other Financing Charges
-18.48
+64.70%
-52.35
-180.60%
-18.66
-159.65%
-7.18
Changes In Cash
-280.73
-188.59%
316.89
+0.71%
314.65
+851.73%
-41.86
Effect Of Exchange Rate Changes
22.45
+8701.96%
0.26
-88.30%
2.18
+391.83%
-0.75
Beginning Cash Position
784.44
+67.87%
467.29
+210.56%
150.47
-22.07%
193.07
End Cash Position
526.16
-32.93%
784.44
+67.87%
467.29
+210.56%
150.47
Free Cash Flow
579.02
+42.89%
405.21
+145.25%
165.22
+58.23%
104.42
Income Tax Paid Supplemental Data
98.92
-37.60%
158.51
+57.57%
100.59
+29.26%
77.82
Amortization Of Securities
—
-0.64
-180.08%
0.79
-85.28%
5.39
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category